PROPRIO-ATA: Evaluation of Proprioception in Patients With Total Hip Replacement

Sponsor
Istituto Ortopedico Rizzoli (Other)
Overall Status
Withdrawn
CT.gov ID
NCT05763368
Collaborator
(none)
0
1
2
24
0

Study Details

Study Description

Brief Summary

Disturbances of balance and postural stability are frequent in patients with coxarthrosis due to the damage to the mechanoreceptors, characteristic of arthritic degeneration, and muscular hypotrophy of the affected limb.

The aim of the study is to evaluate with adequate instrumentation the alterations of proprioception and postural control in patients with hip osteoarthrosis and the effectiveness of joint reconstruction in improving any deficit.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Clinical tests and proprioception evaluation
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Evaluation of Proprioception in Patients With Total Hip Replacement
Actual Study Start Date :
Apr 1, 2022
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Minimally Invasive Lateral Approach

Diagnostic Test: Clinical tests and proprioception evaluation
Each patient will be evaluated using clinical scales (BBS, HHS, HOOS, SF12) and ''Delos Proprioceptive System'' to assess postural stability and proprioception.

Active Comparator: Anterior Approach

Diagnostic Test: Clinical tests and proprioception evaluation
Each patient will be evaluated using clinical scales (BBS, HHS, HOOS, SF12) and ''Delos Proprioceptive System'' to assess postural stability and proprioception.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline postural stability and proprioception [Before the surgery, 3 months, 6 months, and 12 months from surgery]

    Improvement of stability, evaluated with Berg Balance Scale

  2. Change from baseline postural stability and proprioception [Before the surgery, 3 months, 6 months, and 12 months from surgery]

    Improvement of stability and proprioception, evaluated with Delos Proprioceptive System

Secondary Outcome Measures

  1. Clinical improvements [Before the surgery, 3 months, 6 months, and 12 months from surgery]

    Evaluation of clinical improvements using the Harris Hip Score

  2. Clinical improvements [Before the surgery, 3 months, 6 months, and 12 months from surgery]

    Evaluation of clinical improvements using the Patient Reported Outcome Measures with HOOS (Hip disability and Osteoarthritis Outcome Score) Physical Function shortform (HOOS-PS)

  3. Patient satisfaction [Before the surgery, 3 months, 6 months, and 12 months from surgery]

    Evaluation of patient satisfaction using the 12-Item Short Form Health Survey (SF-12)

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Primary Osteoarthrosis

  • BMI < 35 kg/m^2

  • Able to stand in monopodalic support without aids / support

Exclusion Criteria:
  • History of previous hip or knee replacement

  • Orthopedic trauma within the previous 6 months

  • Pathologies that can interfere with balance: neurological (of the central nervous system, neuropathies, movement disorders), vestibular, visual, cognitive disability, consumption of alcohol / drugs / psychoactive drugs in the 24 hours prior to the test

Contacts and Locations

Locations

Site City State Country Postal Code
1 IRCCS-Istituto Ortopedico Rizzoli Bologna Italy 40136

Sponsors and Collaborators

  • Istituto Ortopedico Rizzoli

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mariagrazia Benedetti, Rehabilitation Unit Head, Istituto Ortopedico Rizzoli
ClinicalTrials.gov Identifier:
NCT05763368
Other Study ID Numbers:
  • 0004373
First Posted:
Mar 10, 2023
Last Update Posted:
Mar 10, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2023